India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

Metabolic hypogonadism, a condition marked by low testosterone levels and frequently seen in obese individuals, contributes to worsening metabolic health and an increased risk of type 2 diabetes.

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

You were never warned your biology would change overnight… but today, science shows there's a faster, easier way to get back in shape at any age.

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

A recent study reveals that weight tends to be regained after discontinuing anti-obesity medications (AOMs) such as Ozempic, despite initial successful weight loss.

For adults with type 2 diabetes and obesity, GLP-1 RAs are associated with a lower risk for dementia, stroke, and all-cause mortality.

A TikTokker posting under the name @JonBoy_LosesIt has shared his attitude to the loose skin he's been left with after losing ...

It would work, for a while, and she would lose some weight. Ultimately, however, “I couldn’t get over the obsession with food ...